Welcome

United Therapeutics is the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through (a) the development of novel pharmaceutical therapies; and (b) technologies that expand the availability of transplantable organs. At the same time, we seek to provide our shareholders with superior financial performance and our communities with earth-sensitive energy utilization.

Explore our robust pipeline

Download our corporate presentation

View our responsibility report

Sign up for email alerts

Contact UTHR

News